Publications of C. W. Turck
All genres
Journal Article (37)
2020
Journal Article
10 (1), 343 (2020)
Modulation of cognition and neuronal plasticity in gain- and loss-of-function mouse models of the schizophrenia risk gene Tcf4. TRANSLATIONAL PSYCHIATRY
Journal Article
41 (6), pp. 709 - 714 (2020)
Lipid metabolism is associated with temperament, corticosteroid, and hematological measures in infant rhesus monkeys (Macaca mulatta). ZOOLOGICAL RESEARCH
Journal Article
11, 518 (2020)
Paroxetine Administration Affects Microbiota and Bile Acid Levels in Mice. FRONTIERS IN PSYCHIATRY
Journal Article
11, 496 (2020)
Plasma Metabolite Profiles in First Episode Psychosis: Exploring Symptoms Heterogeneity/Severity in Schizophrenia and Bipolar Disorder Cohorts. FRONTIERS IN PSYCHIATRY
Journal Article
13 (1), 19 (2020)
Proteomic analysis of synaptic protein turnover in the anterior cingulate cortex after nerve injury. MOLECULAR BRAIN
Journal Article
129, pp. 8 - 14 (2020)
Paroxetine binding and activation of phosphofructokinase implicates energy metabolism in antidepressant mode of action. JOURNAL OF PSYCHIATRIC RESEARCH
Journal Article
18, pp. 1914 - 1924 (2020)
Genome-wide circadian regulation: A unique system for computational biology. COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL
Journal Article
10 (4), 128 (2020)
The ABRF Metabolomics Research Group 2016 Exploratory Study: Investigation of Data Analysis Methods for Untargeted Metabolomics. METABOLITES
Journal Article
40, pp. S418 - S419 (2020)
Mechanistic basis behind the antidepressant response of ketamine and hydroxynorketamine (HNK). EUROPEAN NEUROPSYCHOPHARMACOLOGY 2019
Journal Article
15 (9), e1008358 (2019)
Multi-omics analysis identifies mitochondrial pathways associated with anxiety-related behavior. PLoS Genetics
Journal Article
20 (3), 485 (2019)
FKBP5 Gene Expression Predicts Antidepressant Treatment Outcome in Depression. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Journal Article
36 (12), pp. 1173 - 1181 (2019)
Exposure-induced changes of plasma metabolome and gene expression in patients with panic disorder. DEPRESSION AND ANXIETY
Journal Article
13, 833 (2019)
Unraveling the Serum Metabolomic Profile of Post-partum Depression. FRONTIERS IN NEUROSCIENCE 2018
Journal Article
6, 21 (2018)
Fluoxetine Administration in Juvenile Monkeys: Implications for Pharmacotherapy in Children. FRONTIERS IN PEDIATRICS
Journal Article
22 (3), pp. 748 - 759 (2018)
Rapid Turnover of Cortical NCAM1 Regulates Synaptic Reorganization after Peripheral Nerve Injury. CELL REPORTS
Journal Article
8, 179 (2018)
Blood plasma/IgG N-glycome biosignatures associated with major depressive disorder symptom severity and the antidepressant response. SCIENTIFIC REPORTS 2016
Journal Article
21 (2), pp. 277 - 289 (2016)
FKBP51 inhibits GSK3 beta and augments the effects of distinct psychotropic medications. MOLECULAR PSYCHIATRY Book Chapter (1)
2019
Book Chapter
Interactome Studies of Psychiatric Disorders. In: REVIEWS ON BIOMARKER STUDIES IN PSYCHIATRIC AND NEURODEGENERATIVE DISORDERS, pp. 163 - 173 (2019)
Meeting Abstract (2)
2022
Meeting Abstract
12, p. 31 - 31. (2022)
Characterization of cystatin B interactome in saliva of Alzheimer's disease patients. In FEBS OPEN BIO,
Meeting Abstract
63, p. E101 - E101. (2022)
GENOME-WIDE ANALYSIS IDENTIFIES SORCS3 AS A NOVEL SUSCEPTIBILITY LOCUS FOR PANIC DISORDER IN THE FINNGEN STUDY. In EUROPEAN NEUROPSYCHOPHARMACOLOGY,